Studies of Kidney Transplant Outcome

NCT ID: NCT01277770

Last Updated: 2019-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2019-05-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is looking at information already collected of transplant outcomes (short, medium and long-term complications and quality of life). This will specifically look at:

1. 10 year follow-up of steroid-free maintenance immunosuppression
2. A cross-sectional study of infection after kidney transplantation (with emphasis on infection in steroid-free recipients
3. An evaluation of the Delayed Graft Function (DGF) nomogram in Thymoglobulin treated recipients at the University of Minnesota

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transplant Recipient (Kidney) Steroid-Free Maintenance Immunosuppression Post-Transplant Infections Thymoglobulin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kidney Transplant Recipients

Kidney Transplant Recipients at the University of Minnesota since 1984. The study looks at a 10 year followup of steroid-free maintenance immunosuppression, post-transplant infections and evaluation of the DGF nomogram in Thymoglobulin on patients at the University of Minnesota.

Steroid-Free Maintenance Immunosuppression

Intervention Type DRUG

10 year follow-up of steroid-free maintenance immunosuppression

Infection After Kidney Transplantation

Intervention Type OTHER

A cross-sectional study of infection after kidney transplantation (with emphasis on infection in steroid-free recipients).

Evaluation of the DGF nomogram in Thymoglobulin

Intervention Type DRUG

An evaluation of the DGF nomogram in Thymoglobulin treated recipients at the University of Minnesota

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Steroid-Free Maintenance Immunosuppression

10 year follow-up of steroid-free maintenance immunosuppression

Intervention Type DRUG

Infection After Kidney Transplantation

A cross-sectional study of infection after kidney transplantation (with emphasis on infection in steroid-free recipients).

Intervention Type OTHER

Evaluation of the DGF nomogram in Thymoglobulin

An evaluation of the DGF nomogram in Thymoglobulin treated recipients at the University of Minnesota

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Steroid-Free Immunosuppression Infection Transplantation Steroid-Free Thymoglobulin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Kidney Transplant Recipient at the University of Minnesota
* Kidney Transplant Recipients on steroid-free maintenance immunosuppression

Exclusion Criteria

* Non-kidney transplant patients at the University of Minnesota
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Genentech, Inc.

INDUSTRY

Sponsor Role collaborator

University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arthur Matas, MD

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Of Minnesota

Minneapolis, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00011652

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.